WATSU therapy for individuals with Parkinson's disease to improve quality of sleep and quality of life: A randomized controlled study.
Complement Ther Clin Pract
; 46: 101523, 2022 Feb.
Article
en En
| MEDLINE
| ID: mdl-34923216
BACKGROUND: and Purpose: Sleep disorders are one of the most frequent non-motor symptoms of Parkinson's disease (PD). This study aimed to verify whether adding WATSU to land-based therapy leads to additional beneficial therapeutic effects regarding quality of sleep and quality of life (QOL) in individuals with PD. MATERIALS & METHODS: A randomized control trial design was used. Participants completed nine-week interventions. The control group (CG) received land-based therapy, while the intervention group (IG) received the same land-based therapy and additionally WATSU. Sleep quality and QOL were measured at baseline and post-interventions by Pittsburgh Sleep Quality Index and Nottingham Health Profile, respectively. RESULTS: Twenty-eight participants completed the study. In contrast to CG, the IG presented with significant improvements in both, quality of sleep and QOL (p < 0.001). CONCLUSION: WATSU has the potential to be an attractive adjunct therapy for producing positive health impacts regarding sleep quality, which may translate to an overall improvement in QOL of individuals with PD.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedad de Parkinson
/
Trastornos del Sueño-Vigilia
/
Hidroterapia
Tipo de estudio:
Clinical_trials
/
Etiology_studies
Aspecto:
Patient_preference
Límite:
Humans
Idioma:
En
Revista:
Complement Ther Clin Pract
Asunto de la revista:
ENFERMAGEM
/
OBSTETRICIA
/
PERINATOLOGIA
/
TERAPIAS COMPLEMENTARES
Año:
2022
Tipo del documento:
Article
Pais de publicación:
Reino Unido